Import of AIDS drugs streamlined

    By Shan Juan (China Daily)
    Updated: 2007-12-03 07:48

    The top food and drug agency is streamlining approval procedures for importing drugs to treat the estimated 85,000 patients in the country suffering from full-blown AIDS.

    The move came after China released its HIV/AIDS prevalence and prevention assessment report for this year on Thursday, which stated that about 700,000 people in the country are living with AIDS and the HIV virus which causes the disease.

    Zhang Wei, director with the drug registration department of the State Food and Drug Administration (SFDA), said his administration has always attached great importance to importing AIDS drugs.

    "The approval work (for imported AIDS drugs) has never stopped," Zhang said.

    He said a streamlined approval method has been adopted for imports of drugs that show significant clinical effects in treating diseases such as AIDS and cancer.

    A regulation on drug approval was also amended in July making procedures more transparent and efficient, which could see certain procedures going faster in special cases.

    It costs 120 working days to register an AIDS drug compared with 150 for most others, Zhang said.

    Approval for the import of TDF, a key drug in the second line of anti-retroviral treatment also known as the cocktail therapy for AIDS, is currently under way and is expected to be completed in time, he said.

    The United States-based Gliead, the drug's developer, filed the required application in August, said Zhang.

    So far, only seven kinds of AIDS drugs mainly prescribed for first-line anti-retroviral treatment are available in China, with 37,497 AIDS patients reportedly getting free treatment with government aid.

    About 10 percent of patients on the first-line treatment, however, develop resistance after taking the drugs for one year and have to switch to the second-line drugs to survive, said Hao Yao, deputy director with the disease control department of the Health Ministry.

    To reduce the drug resistance also faced by AIDS patients in other countries, Hao strongly urged Chinese patients to stick to their treatment as many kinds of drugs in the second-line cocktail treatment such as TDF are still unavailable here and have to be imported from foreign countries.

    "We are aware of the pressing issues and are considering further measures and policies," Zhang said.

    Last week, the SFDA approved the import of Lopinavir/ritonavir, produced by the US-based Abbott Laboratories, which is also a crucial part of the second-line cocktail treatment.

    In another development, the Ministry of Health has launched a pilot scheme on second-line therapy in Henan, Anhui and Hubei provinces, said Hao.

    "This will be further expanded to the whole country," he said.



    Top China News  
    Today's Top News  
    Most Commented/Read Stories in 48 Hours
    亚洲国产精品无码专区在线观看| 亚洲色成人中文字幕网站| 日韩免费a级毛片无码a∨| 99高清中文字幕在线| 秋霞鲁丝片Av无码少妇| 开心久久婷婷综合中文字幕| 国产亚洲精久久久久久无码AV| 中文无码字慕在线观看| 欧美日韩久久中文字幕| 蜜桃臀无码内射一区二区三区| 中文字幕一区二区三区永久| 日本按摩高潮a级中文片| 久久亚洲AV成人出白浆无码国产 | 大地资源中文第三页| 国产精品无码久久四虎| 亚洲日韩乱码中文无码蜜桃臀网站| 中文字幕乱码人妻一区二区三区| 人妻夜夜添夜夜无码AV| 中文字幕乱偷无码AV先锋| 最近2018中文字幕在线高清下载| 中文成人无码精品久久久不卡| 国产成人精品无码片区在线观看 | 日韩av无码中文字幕| 国产在线拍偷自揄拍无码| 最近2019免费中文字幕6| 乱人伦中文无码视频在线观看| 亚洲?V无码成人精品区日韩| 无码国内精品久久人妻蜜桃| 亚洲欧洲无码AV电影在线观看| 亚洲JIZZJIZZ中国少妇中文| 日韩中文在线视频| 波多野结衣中文字幕在线| 99re热这里只有精品视频中文字幕 | 秋霞鲁丝片Av无码少妇| 少妇伦子伦精品无码STYLES | 中文字幕精品一区| 亚洲国产精品狼友中文久久久| 亚洲电影中文字幕| 最近中文字幕高清字幕在线视频| 亚洲日本va午夜中文字幕一区| 一区二区三区观看免费中文视频在线播放 |